Nucleic Acid Amplification Bias Reduction via Ligation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing nucleic acid amplification methods, such as PCR and isothermal techniques, often suffer from amplification bias when amplifying short nucleic acid sequences like microRNAs, which can lead to variations based on sequence and abundance, making it challenging to accurately determine the relative amounts of multiple target nucleic acids in a sample.

Innovation Solution

A method involving the ligation of two or more different target nucleic acids to form a ligated product, which is then amplified, allowing for the simultaneous amplification of multiple targets while reducing amplification bias by using adaptor and primer sequences with specific GC content and lengths, and subsequently determining the relative amounts through quantitative real-time PCR.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional amplification methods (PCR or isothermal techniques) are used to amplify multiple target nucleic acids, then amplification can be achieved, but amplification bias occurs due to variations in sequence and abundance

Engineering Contradiction:
Improveamplification capabilityVSAvoidaccuracy of relative amount determination
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The patent merges multiple different target nucleic acids into a single ligated product by ligating them together with adaptor sequences. This combining approach allows simultaneous amplification of multiple targets in one reaction, improving productivity while the ligated structure ensures proportional representation, thereby maintaining measurement precision.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent introduces adaptor sequences as intermediary elements that ligate multiple target nucleic acids together. These adaptors serve as mediators that enable simultaneous amplification while preserving the relative abundance information of each target, thus resolving the contradiction between amplification capability and measurement accuracy.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If multiple target nucleic acids are amplified individually, then each target can be amplified, but the process is time-consuming and inefficient

Engineering Contradiction:
Improveaccuracy of individual target amplificationVSAvoidtotal amplification time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent combines multiple individual amplification processes into a single simultaneous amplification reaction by ligating multiple targets into one product. This merging eliminates the need for separate amplification steps for each target, dramatically reducing time loss while maintaining the ability to accurately measure each individual target's relative amount through quantitative real-time PCR.

Inventive Principle:
Principle #5Merging (Combining)

3Productivity

If amplification is performed on short nucleic acid sequences like microRNAs, then amplification can occur, but amplification bias varies according to sequence composition (AT content or GC content)

Engineering Contradiction:
Improveamplification of short sequencesVSAvoidamplification bias
Core Design Contradiction:
ProductivityVSStability of the object's composition

Solution Approach 1:

The patent uses adaptor sequences as intermediaries that ligate to the ends of short nucleic acid sequences. These adaptors provide standardized ends that facilitate efficient ligation and amplification while the ligated structure ensures that amplification efficiency is normalized across different sequences, reducing bias related to AT or GC content variations.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the structural parameters of short nucleic acid sequences by ligating them into larger constructs with standardized adaptor sequences. This parameter change (from short individual sequences to ligated products with adaptors) improves amplification productivity while the standardized structure reduces amplification bias across different sequence compositions.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the accurate and proportional amplification of multiple target nucleic acids, reducing amplification bias and allowing for precise determination of their relative amounts, thereby improving the accuracy of nucleic acid profiling in samples.

Implementation Method 1

The amplification of a nucleic acid includes methods that require multiple cycles during the amplification process, and methods that are performed at a single temperature. Cycling techniques are exemplified by methods requiring thermo-cycling, such as polymerase chain reaction (PCR).

Methodology Applied
Scientific EffectPolymerase chain reaction:

Implementation Method 2

PCR generally involves thermally denaturing a double-stranded DNA to provide single stranded DNAs

Methodology Applied
Scientific EffectThermal denaturation:

Implementation Method 3

annealing a primer to the single stranded DNA; and synthesizing a complementary strand from the primer

Methodology Applied
Scientific EffectAnnealing: Annealing

Implementation Method 4

the isothermal techniques rely on a strand displacing polymerase in order to separate the two strands of a double strand and re-copy the template

Methodology Applied
Scientific EffectStrand displacement:

Data Source

PatentUS8945844B2Method of amplifying target nucleic acid with reduced amplification bias and method for determining relative amount of target nucleic acid in sample
Publication Date: 2015.02.03 SAMSUNG ELECTRONICS CO LTD
  • US8945844B2 patent drawing

AI summary

A method of amplifying a target nucleic acid with reduced amplification bias and a method of determining a relative amount of a target nucleic acid in a sample.